(The Canadian Press)

By Tom Murphy, The Associated Press

J&J suspends COVID-19 vaccine sales forecast

Apr 19, 2022 | 8:20 AM

Johnson & Johnson is suspending sales forecasts for its COVID-19 vaccine only a few months after saying the shot could bring in as much as $3.5 billion this year.

The health care giant said Tuesday that a supply surplus and demand uncertainty prompted the move.

J&J’s one-shot vaccine brought in $457 million in global sales during the first quarter, with most of that coming from outside the United States. The vaccine brought in only $75 million in U.S. sales.

That’s less than what it rang up after debuting in last year’s quarter.

(The Associated Press)

Nighttime construction on Hwy 3 in Lethbridge starts April 17

Apr 17, 2025

SASHA launches #BuyABed fundraiser to support vulnerable Lethbridge residents

Apr 04, 2025

$20K grants available: TELUS STORYHIVE Pan-Asian Edition opens applications April 1

Mar 18, 2025